FloridaChimeric Antigen Receptor T-cell Therapy
What it does
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Died
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Jun 16Died in Banking and InsuranceDied
- May 3Indefinitely postponed and withdrawn from considerationMajor
- Mar 4IntroducedMinor
- Feb 28Referred to Banking and Insurance; Judiciary; RulesMinor
- Feb 19FiledIntroduced